Vertex Pharmaceuticals Incorporated: Vertex to Present New Data on JOURNAVX That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures
Vertex Pharmaceuticals Incorporated: Vertex to Present New Data on JOURNAVX That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures is drawing significant interest across the industry.
-Over 90% of patients in the study were opioid free through the end of multimodal treatment with JOURNAVX- -These data have been accepted for oral presentation at the American Academy of Pain Medicine
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- B&M's £18 garden ornament rivalling £18 Home Bargains sold-out version
- Changing City: Access control road project to decongest Mumbai’s WEH, EEH: BMC kicks off construction on new U-turn flyover at BKC connector
- How an AI Development Company in the USA Is Helping SMBs to Achieve Real-World ROI?
- The Daily Chase: Housing market still sluggish
Source: Original →